Non-hepatitis virus associated mixed essential cryoglobulinemia

Kidney International

Volumn 77, Issue 2, 2010, Pages 161-164

  Annear, Nicholas M P ^a   Cook, H Terence ^a   Atkins, Mark ^b   Pusey, Charles D ^a   Salama, Alan D ^a  

^a HAMMERSMITH HOSPITAL   (United Kingdom)

^b CHELSEA AND WESTMINSTER HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANALGESIC AGENT; CEFALEXIN; METRONIDAZOLE; RITUXIMAB; STEROID;

ADULT; ANAMNESIS; ARTHRALGIA; ARTICLE; BLOOD EXAMINATION; BLOOD TRANSFUSION; BONE MARROW EXAMINATION; CASE REPORT; CREATININE BLOOD LEVEL; CRYOGLOBULINEMIA; DIARRHEA; DRUG WITHDRAWAL; ECHOCARDIOGRAPHY; ELECTRON MICROSCOPY; EMERGENCY WARD; EPISTAXIS; FAMILY HISTORY; FATIGUE; FEMALE; HEMATURIA; HEPATITIS; HUMAN; HUMAN TISSUE; KIDNEY BIOPSY; LABORATORY TEST; LEG EDEMA; PRIORITY JOURNAL; PROTEINURIA; RASH; THORAX RADIOGRAPHY; ULTRASOUND; URINARY TRACT INFECTION;

EID: 73349131073     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/ki.2009.416     Document Type: Article

References (10)

1. Agnello V, Chung RT, Kaplan LM. A role for hepatitis C virus infection in type II cryoglobulinemia. N Engl J Med 1992; 327: 1490-1495.
2. Roccatello D, Fornasieri A, Giachino O et al. Multicenter study on hepatitis C virus-related cryoglobulinemic glomerulonephritis. Am J Kidney Dis 2007; 49: 69-82.
3. Frankel AH, Singer DR, Winearls CG et al. Type II essential mixed cryoglobulinaemia: presentation, treatment and outcome in 13 patients. Q J Med 1992; 82: 101-124.
4. Cohen Tervaert JW, Van Paassen P, Damoiseaux J. Type II cryoglobulinemia is not associated with hepatitis C infection: the Dutch experience. Ann N Y Acad Sci 2007; 1107: 251-258.
5. Saadoun D, Sellam J, Ghillani-Dalbin P et al. Increased risks of lymphoma and death among patients with non-hepatitis C virus-related mixed cryoglobulinemia. Arch Intern Med 2006; 166: 2101-2108.
6. Cacoub P, Delluc A, Saadoun D et al. Anti-CD20 monoclonal antibody (rituximab) treatment for cryoglobulinemic vasculitis: where do we stand? Ann Rheum Dis 2008; 67: 283-287.
7. Tarantino A, Campise M, Banfi G et al. Long-term predictors of survival in essential mixed cryoglobulinemic glomerulonephritis. Kidney Int 1995; 47: 618-623.
8. Salama AD, Pusey CD. Drug insight: rituximab in renal disease and transplantation. Nat Clin Pract Nephrol 2006; 2: 221-230.
9. Basse G, Ribes D, Kamar N et al. Rituximab therapy for mixed cryoglobulinemia in seven renal transplant patients. Transplant Proc 2006; 38: 2308-2310.
10. Pandrangi S, Singh A, Wheeler DE et al. Rituximab treatment for a patient with type I cryoglobulinemic glomerulonephritis. Nat Clin Pract Nephrol 2008; 4: 393-397.